BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6271517)

  • 1. Complete regression of hepatocellular adenoma after withdrawal of oral contraceptives.
    Steinbrecher UP; Lisbona R; Huang SN; Mishkin S
    Dig Dis Sci; 1981 Nov; 26(11):1045-50. PubMed ID: 6271517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver tumor in long-term user of oral contraceptives.
    Ferrara BE; Rutland ED
    Postgrad Med; 1988 Nov; 84(6):107-9. PubMed ID: 2847128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A rare form of benign tumor of the liver possibly related to the use of oral contraceptives: focal pediculated nodular hyperplasia].
    Brouquet J; Chameaud J; Vire O; Fabre P; Catanzano G; Baudet JH
    Rev Fr Gynecol Obstet; 1985; 80(8-9):621-7. PubMed ID: 2997901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transformation of hepatic cell adenoma to hepatocellular carcinoma due to oral contraceptive use.
    Gyorffy EJ; Bredfeldt JE; Black WC
    Ann Intern Med; 1989 Mar; 110(6):489-90. PubMed ID: 2537593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraceptives and focal nodular hyperplasia of the liver.
    Hagay ZJ; Leiberman RJ; Katz M; Witznitzer A
    Arch Gynecol Obstet; 1988; 243(4):231-4. PubMed ID: 3223780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic adenoma within a spindle cell carcinoma in a woman with a long history of oral contraceptives.
    Grigsby P; Meyer JS; Sicard GA; Huggins MB; Lamar DJ; DeSchryver-Kecskemeti K
    J Surg Oncol; 1987 Jul; 35(3):173-9. PubMed ID: 2439848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe and prolonged oral contraceptive jaundice.
    Lieberman DA; Keeffe EB; Stenzel P
    J Clin Gastroenterol; 1984 Apr; 6(2):145-8. PubMed ID: 6715853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible association between benign hepatomas and oral contraceptives.
    Baum JK; Bookstein JJ; Holtz F; Klein EW
    Lancet; 1973 Oct; 2(7835):926-9. PubMed ID: 4126557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalized peliosis hepatis and cirrhosis after long-term use of oral contraceptives.
    van Erpecum KJ; Janssens AR; Kreuning J; Ruiter DJ; Kroon HM; Grond AJ
    Am J Gastroenterol; 1988 May; 83(5):572-5. PubMed ID: 3129933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Spontaneous regression of a large liver tumor with markedly elevated serum enzyme levels].
    Siegel EG; Hartmann H
    Z Gastroenterol; 1987 Dec; 25(12):764-8. PubMed ID: 2830733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 40-1982. Tender hepatomegaly in a 29-year-old woman.
    N Engl J Med; 1982 Oct; 307(15):934-42. PubMed ID: 7110274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of liver cell adenoma. A follow-up study of three consecutive patients after discontinuation of oral contraceptive use.
    Bühler H; Pirovino M; Akobiantz A; Altorfer J; Weitzel M; Maranta E; Schmid M
    Gastroenterology; 1982 Apr; 82(4):775-82. PubMed ID: 6277724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver-cell adenoma. Case report.
    Christensen M; Støckel M; Balslev I
    Acta Chir Scand; 1986 Oct; 152():633-5. PubMed ID: 3028021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
    Lemay A; Dewailly SD; Grenier R; Huard J
    J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eight years of fertility control with norgestrel-ethinyl estradiol (Ovral): an updated clinical review.
    Korba VD; Heil CG
    Fertil Steril; 1975 Oct; 26(10):973-81. PubMed ID: 1183625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris.
    Lucky AW; Henderson TA; Olson WH; Robisch DM; Lebwohl M; Swinyer LJ
    J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):746-54. PubMed ID: 9366821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolution of a contraceptive-steroid-induced hepatic adenoma with subsequent evolution into hepatocellular carcinoma.
    Gordon SC; Reddy KR; Livingstone AS; Jeffers LJ; Schiff ER
    Ann Intern Med; 1986 Oct; 105(4):547-9. PubMed ID: 3019201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic neoplasia: selected clinical aspects.
    Schiff L
    Semin Roentgenol; 1983 Apr; 18(2):71-4. PubMed ID: 6191395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.